USFDA APPLICATION NUMBER - 200533 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
tapentadol hydrochloride(UNII: 71204KII53) (tapentadol - UNII:H8A007M585) | tapentadol | 100mg |
Inactive Ingredients
Ingredient Name | Janssen Pharmaceuticals, Inc. | Lake Erie Medical DBA Quality Care Products LLC |
---|---|---|
.ALPHA.-TOCOPHEROL(H4N855PNZ1) | ||
ALUMINUM OXIDE(LMI26O6933) | ||
FD&C BLUE NO. 2(L06K8R7DQK) | ||
ferric oxide yellow(EX438O2MRT) | ||
FERROSOFERRIC OXIDE(XM0M87F357) | ||
HYPROMELLOSE, UNSPECIFIED (3NXW29V3WO) | ||
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | ||
hypromelloses(3NXW29V3WO) | ||
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | ||
polyethylene glycols(3WJQ0SDW1A) | ||
polyvinyl alcohol(532B59J990) | ||
POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990) | ||
PROPYLENE GLYCOL (6DC9Q167V3) | ||
PROPYLENE GLYCOL(6DC9Q167V3) | ||
SHELLAC (46N107B71O) | ||
shellac(46N107B71O) | ||
TALC(7SEV7J4R1U) | ||
TITANIUM DIOXIDE (15FIX9V2JP) | ||
TITANIUM DIOXIDE(15FIX9V2JP) |